DE69828620D1 - Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut - Google Patents

Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut

Info

Publication number
DE69828620D1
DE69828620D1 DE69828620T DE69828620T DE69828620D1 DE 69828620 D1 DE69828620 D1 DE 69828620D1 DE 69828620 T DE69828620 T DE 69828620T DE 69828620 T DE69828620 T DE 69828620T DE 69828620 D1 DE69828620 D1 DE 69828620D1
Authority
DE
Germany
Prior art keywords
compositions
treating
preventing
human skin
chronological aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828620T
Other languages
English (en)
Other versions
DE69828620T2 (de
Inventor
James Varani
J Fisher
J Voorhees
Sewon Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26717212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69828620(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Michigan filed Critical University of Michigan
Publication of DE69828620D1 publication Critical patent/DE69828620D1/de
Application granted granted Critical
Publication of DE69828620T2 publication Critical patent/DE69828620T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69828620T 1997-02-25 1998-02-23 Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut Expired - Lifetime DE69828620T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4059497P 1997-02-25 1997-02-25
US40594P 1997-02-25
US4297P 1997-04-07
US4297697P 1997-04-08 1997-04-08
PCT/US1998/003743 WO1998036742A1 (en) 1997-02-25 1998-02-23 Methods and compositions for preventing and treating chronological aging in human skin

Publications (2)

Publication Number Publication Date
DE69828620D1 true DE69828620D1 (de) 2005-02-17
DE69828620T2 DE69828620T2 (de) 2005-12-01

Family

ID=26717212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828620T Expired - Lifetime DE69828620T2 (de) 1997-02-25 1998-02-23 Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut

Country Status (10)

Country Link
US (2) US6630516B2 (de)
EP (1) EP1005333B1 (de)
JP (2) JP2002515898A (de)
CN (1) CN100360121C (de)
AU (1) AU737376B2 (de)
BR (1) BR9807854A (de)
CA (1) CA2281944C (de)
DE (1) DE69828620T2 (de)
IL (1) IL131543A (de)
WO (1) WO1998036742A1 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281944C (en) * 1997-02-25 2007-05-15 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
CN100591328C (zh) * 1999-11-16 2010-02-24 荷兰联合利华有限公司 含有鹰嘴豆提取物和类维生素a化合物的化妆品组合物
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20030199574A1 (en) 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
WO2001066080A1 (en) * 2000-03-07 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
AU2001242502A1 (en) * 2000-03-31 2001-10-15 Henkel Kommanditgesellschaft Auf Aktien Use of protease inhibitors in cosmetics and pharmacy
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2004504276A (ja) * 2000-06-26 2004-02-12 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン ヒトの皮膚の光老化を防止するためのｅｇｆ−ｒタンパク質チロシンキナーゼ抑制剤の使用
US20040185127A1 (en) * 2001-06-29 2004-09-23 Lerner David S. Cosmetic composition and method
FR2811561B1 (fr) * 2000-07-13 2003-03-21 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
US20020119107A1 (en) * 2000-12-18 2002-08-29 James Varani Method for protecting and restoring skin using selective MMP inhibitors
US6734858B2 (en) * 2000-12-27 2004-05-11 Avon Products, Inc. Method and apparatus for use of computer aging to demonstrate a product benefit
DE10102784A1 (de) * 2001-01-22 2002-08-01 Henkel Kgaa Kosmetische oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US7713942B2 (en) * 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
FR2826266B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
EP1439855A4 (de) * 2001-09-25 2009-02-11 Quick Med Technologies Inc Zusammensetzung und verfahren zur minimierung oder vermeidung von unerwünschten vesikans-wirkungen
EP1297830A1 (de) * 2001-09-28 2003-04-02 Flamma Fabbrica Lombarda Ammino Acidi S.p.a. Verwendung von alpha- oder beta-Aminosäuren oder deren Ester oder von Dipeptiden dieser Aminosäuren mit Histidinderivaten zur Vermeidung oder Behandlung von Gewebeschäden durch Einwirkung atmosphärischen Ozons
US7354956B2 (en) 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
US20040033246A1 (en) * 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
JP2006522660A (ja) * 2003-04-10 2006-10-05 ライト バイオサイエンス，エルエルシー 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置
ES2572976T3 (es) 2003-07-31 2016-06-03 Gentlewaves Llc Sistema y método para el tratamiento fotodinámico de la piel
WO2005019162A1 (en) 2003-08-26 2005-03-03 Amorepacific Corporation Hydroxamic acid derivatives and the method for preparing thereof
WO2006053415A1 (en) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
EP1718732B1 (de) * 2004-01-27 2013-10-30 The Hospital for Sick Children Research Institute Verfahren zur herstellung und verwendung von der haut abgeleiteter stammzellen
WO2005072696A1 (en) * 2004-01-30 2005-08-11 Ace Aps Use of ace inhibitors and/or angiotensin ii receptor antagonists for the improving and/or maintaining the skin tone and for the treatment of skin ageing
ES2363978T3 (es) * 2004-02-13 2011-08-22 Cognis France, S.A.S. Uso de composiciones cosméticas que comprenden un extracto de las hojas de castanea sativa.
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
SI1591105T1 (sl) 2004-03-17 2020-09-30 Stada Arzneimittel Ag Uporaba antioksidantov za pripravo farmacevtskega ali kozmetičnega sestavka za zaščito kože pred poškodbo z infrardečim sevanjem
JP4921351B2 (ja) 2004-03-26 2012-04-25 ディーエスエム アイピー アセッツ ビー．ブイ． レチノイドと組み合せたｈｄａｃインヒビターを含む組成物
EP2377532A1 (de) * 2004-08-18 2011-10-19 Ace ApS Kosmetische und pharmazeutische Zusammensetzungen mit ACE-Hemmern und/oder Angiotensin-II-Rezeptorantagonisten zur Behandlung von Hauterkrankungen
JP4777738B2 (ja) * 2004-10-14 2011-09-21 株式会社 資生堂 Ａｄａｍ活性阻害物質によるしわの防止または改善
FR2877220B1 (fr) * 2004-11-04 2008-10-10 Oreal Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane
US8173144B2 (en) * 2004-11-04 2012-05-08 L'oreal Administration of urea compounds for combating signs of cutaneous aging
US20060265030A1 (en) * 2004-11-12 2006-11-23 Light Bioscience, Llc System and method for photodynamic cell therapy
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
JP4526971B2 (ja) * 2005-02-14 2010-08-18 株式会社資生堂 フィブュリン−５を指標とした皮膚老化状態の評価方法
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US20060275229A1 (en) * 2005-05-17 2006-12-07 Sreekumar Pillai Skin care active complex and methods of using same
EP1837392A1 (de) 2006-03-21 2007-09-26 Chanel Parfums Beauté Öl aus Magnoliae champaca, Verfahren zu dessen Herstellung und sie enthaltende Zusammensetzungen
WO2007134219A2 (en) * 2006-05-11 2007-11-22 Living Proof, Inc. In situ polymerization for skin treatment
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
ES2330291B1 (es) 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2009121168A1 (en) * 2008-04-01 2009-10-08 Biopharmacopae Design International Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection
WO2009127248A1 (en) 2008-04-16 2009-10-22 United Technologies Ut Ag Cosmetic and dermatological compositions and kits containing interleukin-1 alpha
EP2370086A2 (de) * 2008-12-01 2011-10-05 Lifespan Extension Llc Verfahren und zusammensetzungen zur veränderung des gesundheitszustandes, wohlbefindens und der lebenserwartung
JP2012511027A (ja) * 2008-12-04 2012-05-17 チョンシー ユー 高透過性組成物およびその用途
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
WO2011135341A2 (en) * 2010-04-26 2011-11-03 Ame Health Ltd Skin profiling and its use in testing cosmetics
US8546341B2 (en) 2010-05-28 2013-10-01 M. Alphabet, Llc Compositions and methods for treating bruises
US9216209B1 (en) 2011-06-06 2015-12-22 Kilmer S. McCully Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging
US10639252B2 (en) * 2011-09-23 2020-05-05 Allergan, Inc. Compositions for skin exfoliation and use thereof
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
EP2934555B1 (de) 2012-12-21 2021-09-22 Astellas Institute for Regenerative Medicine Verfahren zur herstellung von plättchen aus pluripotenten stammzellen
FR3006191B1 (fr) * 2013-06-03 2016-04-29 Pierre Fabre Dermo-Cosmetique Compositions cosmetiques ou dermatologiques associant du retinaldehyde et de l'oleamide de glycylglycine, et leurs utilisations en cosmetique ou dermatologie
GB201317286D0 (en) 2013-09-30 2013-11-13 Calscience Internat Ltd Composition and Use
EP3253400B1 (de) 2015-02-05 2023-01-18 Muhammed Majeed Oleanoylpeptidzusammensetzung
GB201502268D0 (en) 2015-02-11 2015-04-01 Calscience Internat Ltd Dental composition and use
JP2016222621A (ja) * 2015-06-02 2016-12-28 学校法人九州文化学園 メラニン合成促進組成物
JP2017210442A (ja) * 2016-05-26 2017-11-30 イノレックス インベストメント コーポレイション マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物
JP7258749B2 (ja) * 2017-07-18 2023-04-17 株式会社 資生堂 抗老化物質のスクリーニング方法
JP2018168177A (ja) * 2018-07-03 2018-11-01 イノレックス インベストメント コーポレイション マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物
CN113144192A (zh) * 2020-01-22 2021-07-23 中国科学院上海营养与健康研究所 Mapk/erk通路抑制剂在拮抗皮肤老化与辐射性皮肤早衰中的应用
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
AU636595B2 (en) * 1989-01-19 1993-05-06 Ortho Pharmaceutical Corporation Method for the treatment or prevention of intrinsically aged skin with retinoids
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
LU87843A1 (fr) * 1990-11-15 1992-08-25 Cird Galderma Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
GB9102635D0 (en) * 1991-02-07 1991-03-27 British Bio Technology Compounds
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
JP3277033B2 (ja) * 1993-06-17 2002-04-22 カネボウ株式会社 化粧料
WO1995007924A1 (en) * 1993-09-17 1995-03-23 Andy Shih Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
FR2710839B1 (fr) * 1993-10-08 1995-12-08 Rocher Yves Biolog Vegetale Composition cosmétique et méthode de traitement esthétique s'opposant au vieillissement de la peau.
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2724317B1 (fr) * 1994-09-08 1996-10-18 Oreal Chelateurs de metaux photoclivables et compositions les contenant
US5476661A (en) * 1994-10-21 1995-12-19 Elizabeth Arden Co., Division Of Conopco, Inc. Compositions for topical application to skin, hair and nails
US5614489A (en) * 1995-05-25 1997-03-25 Mohammadi; Fatemeh Method and composition for treating the skin
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
WO1997041242A1 (en) * 1996-04-18 1997-11-06 Geron Corporation Senescence responsive transcriptional element
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
CA2281944C (en) * 1997-02-25 2007-05-15 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin

Also Published As

Publication number Publication date
CA2281944C (en) 2007-05-15
US20040034098A1 (en) 2004-02-19
IL131543A0 (en) 2001-01-28
JP2002515898A (ja) 2002-05-28
CN1251989A (zh) 2000-05-03
JP2010195817A (ja) 2010-09-09
EP1005333A1 (de) 2000-06-07
AU737376B2 (en) 2001-08-16
AU6537498A (en) 1998-09-09
US20010053347A1 (en) 2001-12-20
US6919072B2 (en) 2005-07-19
IL131543A (en) 2005-08-31
EP1005333B1 (de) 2005-01-12
WO1998036742A1 (en) 1998-08-27
BR9807854A (pt) 2000-02-22
DE69828620T2 (de) 2005-12-01
US6630516B2 (en) 2003-10-07
EP1005333A4 (de) 2001-03-14
CA2281944A1 (en) 1998-08-27
CN100360121C (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
DE69828620D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
ATE323500T1 (de) Verfahren und zusammensetzung zur behandlung von verzögerten allergischen reaktionen und entzündungskrankheiten
DE69942680D1 (de) Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
DE60039177D1 (de) Verfahren zur verbesserung der haut und des pelzes von haustieren
ATE197122T1 (de) Hämorrhoidenzusammensetzungen und verfahren zur verwendung
DE69827664D1 (de) Thioharnstoffverbindungen, zusammensetzungen sowie verfahren zur behandlung oder verhütung von entzündlichen erkrankungen und atherosklerose
DE69925266D1 (de) Verfahren und gerät zur behandlung von herzarhythmie
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69820997D1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
ATE250424T1 (de) Zusammensetzungen und verfahren zur anregung des wachstums von neuriten
DE69821913D1 (de) Verfahren zur behandlung der hautpigmentierung
ATE270556T1 (de) Verwendung von synergistischen zusammensetzungen von il-12 und ifn-alpha für die behandlung von infektiösen krankheiten
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
ATE214274T1 (de) Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
ATE280577T1 (de) Oxa-säuren und verwandte verbindungen zur behandlung von störungen der haut
DE69033199D1 (de) Mittel zur feuchthaltung von gewebe und verfahren
ATE349537T1 (de) Verbindung und verfahren zur bekämpfung und/oder behandlung der allergie
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69600100D1 (de) Puderquaste zur örtlichen Behandlung der Haut
DE69911409D1 (de) Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE59509314D1 (de) Haarbehandlungsmittel und Verfahren zur Anwendung
ATE278400T1 (de) Zusammensetzungen für die verwendung bei der behandlung und prävention von hyperurikämie
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition